Patient-control association study of the Leucine-Rich repeat kinase 2 (LRRK2) gene in South African Parkinson's disease patients.

dc.contributor.authorBardien S
dc.contributor.authorBlanckenberg J
dc.contributor.authorvan der Merwe L
dc.contributor.authorFarrer MJ
dc.contributor.authorRoss OA
dc.date.accessioned2014-07-07T12:29:49Z
dc.date.available2014-07-07T12:29:49Z
dc.date.issued2013
dc.descriptionPlease help populate SUNScholar with the full text of SU research output. Also - should you need this item urgently, please send us the details and we will try to get hold of the full text as quick possible. E-mail to scholar@sun.ac.za. Thank you.
dc.descriptionJournal Articles (subsidised)
dc.descriptionGeneeskunde en Gesondheidswetenskappe
dc.descriptionMolekul�re Biologie & Mensgenetika
dc.identifier.citationMovement Disorders
dc.identifier.citation28
dc.identifier.citation2039
dc.identifier.citation2040
dc.identifier.urihttp://hdl.handle.net/10019.1/94324
dc.publisherWILEY-LISS, DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, USA, NJ, 07030
dc.titlePatient-control association study of the Leucine-Rich repeat kinase 2 (LRRK2) gene in South African Parkinson's disease patients.
Files